EpiPen Maker May Have Cheated Government Out Of Millions Of Dollars
Mylan has been accused of classifying EpiPens as a generic drug to pay a smaller rebate to Medicaid.
LEARN MOREHealth insurance giant Cigna and CVS Health have made big moves against the pricey brand-name allergy treatment.
Zepbound was approved last year to treat obesity. The drug's maker, Eli Lilly, says it reduces the severity of obstructive sleep apnea by 63%.
The CDC has noted a rise in emergency room visits among young children who have taken melatonin supplements without supervision.
Opill is available at Walgreens and CVS for $19.99 for a one-month supply and $49.99 for a three-month supply.
Netflix added millions of paying customers in the last year after telling password sharers to get their own subscription.
An advocacy group alleges that Nestle is contributing to a growing number of children with obesity by adding sugar to products in poorer nations.
Swifties have been decoding all the clues and speculating about the significance of the number two. The secret is out, and a double album is here.